Cesar enter my vulva

Magnetic resonance imaging is a method with high contrast resolution widely used in the assessment of pelvic gynecological diseases. However, the potential of such method to diagnose vaginal lesions is still underestimated, probably due to the scarce literature approaching the theme, the poor familiarity of radiologists with vaginal diseases, some of them relatively rare, and to the many peculiarities involved in the assessment of the vagina. Thus, the authors illustrate the role of magnetic resonance imaging in the evaluation of vaginal diseases and the main relevant findings to be considered in the clinical decision making process. Vaginal lesions are detected at physical gynecological examination and, in a large portion of cases, the diagnosis is made by means of biopsy and anatomopathological analysis. Ultrasonography is utilized for complementary evaluation, but with a narrower scanning area and, consequently, limitation for locoregional staging. Computed tomography CT has poor contrast resolution and is limited to the diagnosis of pelvic lymph nodes in malignant diseases.

Vulvar fibroadenomas are sporadic lesions informed in the literature and a controversy about origin has been discussed widely. We report a case of a 19 years old woman with a large slow growing mass in the right labia majora with the final diagnosis of fibroadenoma with mammary tissue surrounding it and positive hormone receptors. In this case, we support the origin in ectopic mammary tissue. Vulvar lesions in general are infrequent. Mesenchymal neoplasms are even less frequent [ 2 ]; vulvar fibroadenoma is one of the mammary-like fibroepithelial lesions of uncertain histogenesis, and is extremely rare [ 2 - 7 ]. These lesions have been reported in the medical literature over the past 50 years [ 2 ].

Back to Pregnancy and child. A technique called vaginal seeding, sometimes used for babies born by caesarean section, "can give newborns deadly infections and sepsis," warns the Mail Online. Vaginal seeding involves rubbing vaginal fluid onto the skin of a newborn baby born by caesarean section. It's intended to mimic the natural transfer of microbes from their mother that babies have during a vaginal birth. This has been reported by some to help boost a baby's response against allergies and asthma.

Demeaning patient behavior takes emotional toll on physicians. Studies have generally been limited to fewer than patients followed for 12 weeks or less. Companies are not informing doctors that the devices may not be FDA approved for the purposes advertised, nor are they providing adverse effects reports.